Disorders of sexual preference

F5_SEXPREF

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 F65
  • Hospital discharge: ICD-9 302[1-2]|3024|3028|3029
  • Hospital discharge: ICD-8 302
  • Hospital discharge: excluded ICD-8 3023
  • Cause of death: ICD-10 F65
  • Cause of death: ICD-9 302[1-2]|3024|3028|3029
  • Cause of death: ICD-8 302
  • Cause of death: excluded ICD-8 3023

2 out of 7 registries used, show all original rules.

82

4. Check minimum number of events

None

82

5. Include endpoints

None

82

6. Filter based on genotype QC (FinnGen only)

82

Control definitions (FinnGen only)

Control exclude
F5_PERSOBEH

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
F63-F69
Name in latin
Perturbationes praeferentiae sexualis

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 921 154 755
Only index persons 675 116 559
Unadjusted period prevalence (%)
Whole population 0.02 0.00 0.02
Only index persons 0.02 0.00 0.02
Median age at first event (years)
Whole population 31.68 28.72 32.05
Only index persons 29.04 23.76 30.13

-FinnGen-

Key figures

All Female Male
Number of individuals 82 11 71
Unadjusted period prevalence (%) 0.03 0.00 0.03
Median age at first event (years) 32.88 28.29 33.59

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

No data

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
77
Matched controls
768
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
F65.4
ICD-10 Finland
Paedophilia
+∞
17.3
16
*
N05AH03
ATC
olanzapine; systemic
44.1
16.7
20
6
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
19.9
16.5
25
18
30200
ICD-8 Finland
Sexual deviation, Homosexuality
+∞
12.9
12
*
30299
ICD-8 Finland
Sexual deviation, Unspecified
+∞
10.7
10
*
N03AG01
ATC
valproic acid; systemic, rectal
11.8
9.4
17
18
N06AB04
ATC
citalopram; systemic
6.0
9.2
28
67
N05AA02
ATC
levomepromazine; systemic
16.8
9.1
14
10
N06AB03
ATC
fluoxetine; oral
7.8
9.0
21
35
N05AX08
ATC
risperidone; systemic
11.9
7.9
14
14
30041
ICD-8 Finland
Neuroses, Depressiva
50.3
7.9
9
*
F61.0
ICD-10 Finland
Mixed personality disorders
88.2
7.6
8
*
30188
ICD-8 Finland
Personality disorders, Alia definita
+∞
7.4
7
*
N05CD07
ATC
temazepam; oral
6.2
7.3
20
41
N05AF03
ATC
chlorprothixene; systemic
33.5
7.3
9
*
N05AX12
ATC
aripiprazole; systemic
18.8
6.9
10
6
N05AB03
ATC
perphenazine; systemic, rectal
18.8
6.9
10
6
N05BA04
ATC
oxazepam; oral
4.5
6.8
26
78
F29
ICD-10 Finland
Unspecified nonorganic psychosis
16.1
6.6
10
7
T36
ICD-10 Finland
Poisoning by systemic antibiotics
10.7
6.6
12
13
N05AN01
ATC
lithium; oral
75.9
6.5
7
*
N05AD01
ATC
haloperidol; systemic
20.1
6.4
9
5
N05AA01
ATC
chlorpromazine; systemic, rectal
29.3
6.4
8
*
F65.9
ICD-10 Finland
Disorder of sexual preference, unspecified
+∞
6.3
6
*
E9509
ICD-8 Finland
Suicide and self-inflicted poisoning by solid or liquid substances, Other and unspecified solid and liquid substances
+∞
6.3
6
*
F65.0
ICD-10 Finland
Fetishism
+∞
6.3
6
*

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40758558) Short blood count panel - Blood
35
163
3.00
5.41
12.7
5.5
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
8
9
9.69
4.38
5.8
2.0
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
7
8
9.42
3.85
27.1
13.3
nmol/l
626.4
620.6
—
7
8
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
7
8
9.42
3.85
35.1
18.3
nmol/l
1035.9
888.4
—
7
8
(3012544) pH of Venous blood
15
54
3.18
3.47
3.9
4.2
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
7
12
6.26
3.09
14.6
2.6
kpa
7.6
8.3
—
7
12
(3011288) Drugs identified in Urine by Screen method
7
15
4.99
2.66
6.6
1.9
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
42
277
2.06
2.61
9.1
8.9
mmol/l
1.2
1.2
0.03
37
234
(3021901) Oxygen saturation in Capillary blood
6
11
5.79
2.59
2.5
2.7
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
8
21
4.10
2.53
5.8
1.5
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
30
176
2.11
2.53
4.7
4.9
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
15
67
2.52
2.34
2.1
1.7
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
9
29
3.36
2.30
5.2
1.7
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
9
29
3.36
2.30
5.2
1.7
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
9
29
3.36
2.30
5.2
1.7
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
9
29
3.36
2.30
5.2
1.7
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
9
29
3.36
2.30
5.7
1.7
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
7
19
3.93
2.20
1.1
1.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
14
265
0.43
2.19
5.4
2.8
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
14
64
2.43
2.08
1.1
2.3
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
32
205
1.92
2.06
3.8
3.1
mmol/l
10.2
8.7
0.48
25
175
(3021589) Normoblasts [#/volume] in Blood
43
306
1.85
1.98
14.1
9.3
e9/l
0.0
0.0
0.37
37
249
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
13
59
2.43
1.96
1.1
2.1
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
22
131
1.93
1.72
3.2
2.8
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
33
225
1.78
1.69
5.6
2.9
e6/l
166.1
47.5
0.68
22
166
(3000492) Spirometry study
13
64
2.23
1.65
1.6
1.4
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
31
209
1.78
1.64
2.5
1.8
pmol/l
87.0
95.5
0.54
19
115
(3011397) Hemoglobin [Presence] in Urine by Test strip
21
125
1.91
1.64
3.5
3.5
—
—
—
0
0
(3000991) Gas panel - Venous blood
11
52
2.29
1.52
13.5
8.3
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
9
39
2.47
1.48
3.3
4.3
g/l
128.1
132.9
—
9
39
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
18
105
1.92
1.48
5.7
2.3
e6/l
0.9
1.1
—
9
60
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
10
46
2.34
1.46
10.7
2.9
kpa
6.1
5.1
—
10
46
(3024891) Influenza virus A+B Ag [Presence] in Specimen
5
16
3.26
1.46
1.2
1.3
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
28
191
1.71
1.39
2.7
3.2
mg/l
44.8
413.9
0.56
19
131
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
6
23
2.73
1.39
2.2
1.6
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
40
302
1.63
1.35
3.3
3.5
estimate
0.4
0.0
—
7
54
(3004588) Protein electrophoresis panel - Serum or Plasma
8
34
2.50
1.33
1.3
2.4
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
5
18
2.89
1.30
1.2
2.4
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
16
94
1.87
1.29
6.1
2.3
e6/l
2.5
1.5
—
7
50
(3052851) Hemolysis interference index of Serum or Plasma
5
19
2.73
1.23
2.2
3.7
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
39
298
1.59
1.22
4.8
4.5
estimate
0.0
0.0
—
6
61
(3022621) pH of Urine by Test strip
8
39
2.16
1.19
1.6
2.2
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
0
34
0.00
1.19
0.0
1.4
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
7
30
2.45
1.15
4.7
3.8
%
47.9
60.8
—
7
30
(3027273) Bicarbonate [Moles/volume] in Venous blood
7
32
2.30
1.11
3.9
4.6
mmol/l
25.6
24.4
—
7
32
(3030467) Casts [#/volume] in Urine by Automated count
27
193
1.59
1.10
5.3
2.5
e6/l
0.6
0.3
0.43
20
141
(3009343) pH of Capillary blood
9
46
2.07
1.08
11.3
2.9
—
7.4
—
0
8
(3036481) Cortisol [Moles/volume] in Serum or Plasma
10
53
2.01
1.06
2.6
1.8
nmol/l
341.0
359.1
—
10
46
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
32
240
1.55
1.06
5.2
2.7
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
7
35
2.09
1.03
3.3
2.4
%
1.2
1.6
—
7
35
(42870588) Differential panel, method unspecified - Blood
29
216
1.53
0.98
8.2
5.3
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
20
137
1.61
0.96
2.5
1.6
mg/l
0.7
0.8
0.36
13
105
(3004716) Salmonella sp identified in Stool by Organism specific culture
6
27
2.32
0.95
2.0
1.1
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
71
645
1.75
0.92
5.5
4.3
mmol/l
6.4
6.1
0.64
65
586
(3018418) pH of Serum or Plasma
24
174
1.54
0.91
3.5
3.7
ph
7.4
7.4
—
5
35
(40760892) CBC W Ordered Manual Differential panel - Blood
20
139
1.58
0.90
9.8
5.2
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
25
184
1.52
0.88
5.4
2.3
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
12
73
1.75
0.87
2.1
1.8
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
33
260
1.45
0.83
3.4
7.9
inr
1.2
1.2
—
7
79
(3001019) Free T4 and TSH panel - Serum or Plasma
0
26
0.00
0.80
0.0
1.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
6
34
1.82
0.78
1.2
1.6
—
—
—
0
0
(3022313) Gas panel - Capillary blood
6
34
1.82
0.78
16.5
2.9
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
29
226
1.44
0.77
2.8
2.5
ug/l
178.8
162.5
0.15
29
209
(3020682) Albumin/Creatinine [Ratio] in Urine
27
208
1.44
0.76
3.4
4.1
mg/mmol
5.0
11.7
0.94
17
140
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
7
39
1.87
0.75
1.9
1.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
7
41
1.77
0.72
1.3
1.7
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
17
120
1.53
0.72
1.5
1.8
—
—
—
0
0
(3020891) Body temperature
5
26
1.98
0.72
4.2
4.7
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
36
295
1.39
0.71
3.4
3.4
estimate
0.0
0.0
—
6
61
(3017143) Hepatitis C virus Ab [Presence] in Serum
12
78
1.63
0.70
2.8
1.8
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
48
414
1.38
0.69
5.8
3.6
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
8
52
1.60
0.61
1.4
1.6
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
8
52
1.60
0.61
3.3
1.8
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
0
20
0.00
0.61
0.0
1.2
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
14
99
1.50
0.59
1.6
1.9
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
13
91
1.51
0.57
1.6
2.3
g/l
2.4
2.4
0.11
13
81
(3022948) Iron [Moles/volume] in Serum or Plasma
14
100
1.48
0.56
1.7
2.3
umol/l
11.6
14.1
0.70
14
91
(3002582) Erythrocytes [#/volume] in Urine
26
209
1.36
0.56
5.5
2.6
e6/l
51.0
40.5
0.09
19
157
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
14
102
1.45
0.51
1.4
1.6
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
13
94
1.46
0.49
1.2
1.2
iu/ml
6.9
27.2
—
7
34
(3019225) pH of Specimen
7
50
1.44
0.46
4.1
3.9
—
—
—
0
0
(4010399)
8
56
1.47
0.44
1.3
1.5
—
—
—
0
0
(3044889) 12 lead EKG panel
52
472
1.28
0.44
4.4
3.7
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
30
256
1.27
0.42
3.4
3.8
ng/l
38.6
28.0
0.20
23
179
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
15
0.00
0.41
0.0
1.6
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.6
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
0
16
0.00
0.41
0.0
1.7
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
68
641
1.36
0.41
19.4
11.7
ml/min/173m2
84.8
84.5
0.03
60
526
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
0
17
0.00
0.41
0.0
1.2
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
18
0.00
0.40
0.0
1.7
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
9
66
1.41
0.40
2.7
3.0
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
17
210
0.76
0.40
3.0
2.0
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
70
665
1.36
0.37
19.7
13.4
mg/l
17.6
24.2
1.61
64
527
(3041096) Erythrocytes [Presence] in Urine by Automated
14
176
0.75
0.37
3.4
3.0
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
10
73
1.42
0.36
11.5
14.5
kpa
6.3
4.9
—
10
68
(40768797) Stomach Pathology biopsy report
11
83
1.38
0.34
1.3
1.3
—
—
—
0
0
(3002256) Pathology report gross observation
5
72
0.67
0.27
1.8
1.2
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
9
72
1.28
0.27
1.7
1.7
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
72
694
1.31
0.26
26.7
15.3
mmol/l
139.1
139.7
1.11
72
675
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
74
718
1.31
0.22
14.8
9.7
u/l
38.1
30.8
0.39
74
694
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
37
400
0.86
0.22
3.2
4.3
ug/l
1.6
2.5
0.56
31
362
(3008757) Leukocyte morphology finding [Identifier] in Blood
0
11
0.00
0.21
0.0
3.0
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
0
11
0.00
0.21
0.0
2.7
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
0
11
0.00
0.21
0.0
1.9
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
0
11
0.00
0.21
0.0
1.9
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.9
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
0
10
0.00
0.21
0.0
2.0
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
0
10
0.00
0.21
0.0
2.0
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
0
10
0.00
0.21
0.0
2.0
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
0
12
0.00
0.21
0.0
1.2
—
8.3
—
0
7
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
1.8
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
0
13
0.00
0.21
0.0
1.8
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
0
13
0.00
0.21
0.0
3.5
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.3
—
606.9
—
0
13
(4035726)
6
49
1.24
0.20
2.0
1.3
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
0
14
0.00
0.20
0.0
1.7
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
(40761535) Cells panel - Urine sediment
6
51
1.19
0.20
3.5
3.8
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
68
657
1.21
0.19
4.5
4.0
mmol/l
1.6
1.4
0.95
63
602
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
10
82
1.25
0.18
1.2
1.6
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
5
67
0.73
0.17
1.0
1.3
—
350.6
—
0
17
(3003694) ABO and Rh group [Type] in Blood
19
169
1.16
0.16
1.6
1.3
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
29
314
0.88
0.16
3.2
3.9
%
21.9
22.0
0.01
13
138
(3007164) IgA [Mass/volume] in Serum or Plasma
14
123
1.17
0.13
1.1
1.3
g/l
2.8
2.4
—
6
71
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
22
239
0.89
0.12
3.9
3.5
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
11
96
1.17
0.11
1.8
2.3
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
26
277
0.91
0.10
5.4
4.2
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
10
87
1.17
0.10
1.8
2.4
%
18.9
23.9
—
10
77
(3019060) Gas panel - Arterial blood
5
46
1.09
0.10
1.4
14.0
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
72
707
1.15
0.09
18.6
12.7
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
43
414
1.08
0.08
2.4
3.2
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
5
64
0.77
0.08
1.0
1.5
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
61
624
0.91
0.08
26.1
13.7
%
39.9
41.6
0.55
44
475
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
7
67
1.05
0.08
10.0
9.5
—
—
—
0
0
(3024731) MCV [Entitic volume]
75
752
0.97
0.08
35.8
19.1
fl
90.4
90.8
0.41
75
740
(3000963) Hemoglobin [Mass/volume] in Blood
75
752
0.97
0.08
36.0
19.2
g/l
139.7
142.0
0.62
75
739
(3035941) MCH [Entitic mass]
75
752
0.97
0.08
35.7
19.0
pg
30.2
30.5
0.62
75
740
(3026361) Erythrocytes [#/volume] in Blood
75
752
0.97
0.08
36.0
19.1
e12/l
4.7
4.7
0.10
75
730
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
8
75
1.07
0.08
1.6
1.8
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
20
192
1.06
0.02
2.8
2.4
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
14
136
1.04
0.00
2.9
2.3
—
—
—
0
0
(3013512) EKG study
18
181
0.99
0.00
4.4
4.0
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
75
751
0.98
0.00
35.8
19.1
e9/l
249.2
234.9
1.28
75
730
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
0
6
0.00
0.00
0.0
1.8
—
33.3
—
0
6
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
2.3
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
2.4
—
119.3
—
0
8
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
4.4
—
147.2
—
0
5
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
0
9
0.00
0.00
0.0
2.1
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
2.3
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
0
7
0.00
0.00
0.0
4.9
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
2.3
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3004451) EKG impression Narrative
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(40768793) Breast Pathology biopsy report
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(21494434) Karyotype in Bone marrow
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3022145) Colonoscopy Study observation
7
73
0.96
0.00
1.0
1.3
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.8
—
1.0
—
0
8
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
4.6
—
63.2
—
0
5
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011648) Oxygen content in Venous blood
0
7
0.00
0.00
0.0
1.6
—
13.0
—
0
7
(3023410) Appearance of Cerebral spinal fluid
0
5
0.00
0.00
0.0
2.8
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.8
—
13.9
—
0
9
(40761536) Microorganisms panel - Urine sediment
5
54
0.92
0.00
4.4
3.4
—
—
—
0
0
(4146454)
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(4306422)
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(4268621)
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
7
0.00
0.00
0.0
1.9
—
13.0
—
0
7
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0

Mortality – FinRegistry

Association

Association between endpoint F5_SEXPREF and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have F5_SEXPREF.

N-year risk Females Males
1 No data No data
5 No data No data
10 No data No data
15 No data No data
20 No data No data

Relationships between endpoints

Index endpoint: F5_SEXPREF – Disorders of sexual preference

GWS hits: 1

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data